A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects
Jan Trøst Jørgensen, Nils Albiin(Umeå University), Matthias Rief(Technical University of Munich), Torkel B. Brismar(Karolinska University Hospital), Moritz Wagner(University of Ottawa)
Cited by 7
Related Papers
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update
|Radiology Artificial Intelligence|2024|406
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial
|JHEP Reports|2021|220
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
|Clinical Nutrition|2015|179